ABEO

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical firm based in New York, NY, dedicated to advancing innovative gene and cell therapies for rare, life-threatening genetic disorders. The company leverages its proprietary technologies and comprehensive clinical development pipeline to address significant unmet medical needs, with an emphasis on enhancing patient outcomes. By pioneering transformative therapeutic solutions, Abeona seeks to establish a robust portfolio of treatments that holds the potential to redefine the landscape of genetic therapies and provide hope to patients encountering severe health challenges.